Trial in progress: a phase 3, randomized, open-label study comparing zanubrutinib plus rituximab versus bendamustine plus rituximab in patients with previously untreated mantle cell lymphoma (MCL)

 ABSTRACT   06/2020

For more information about this publication, please submit a medical information request.

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!